This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n11	http://dx.doi.org/10.1210/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q58448092

rdf:type

wikibase:Item

schema:description

wetenschappelijk artikel im Juni 2011 veröffentlichter wissenschaftlicher Artikel article наукова стаття, опублікована в червні 2011

p:P577

wds:Q58448092-4173A322-A003-40A2-993C-7E21B26E9AA0

wdt:P577

2011-03-30T00:00:00Z

p:P407

wds:Q58448092-499D49DA-C40B-4CDA-989E-EFFE44B326AB

wdt:P407

wd:Q1860

p:P2093

wds:Q58448092-FBAC209A-7710-43B9-9C37-4CE6F064D8F5 wds:Q58448092-DCBF087D-5890-4A24-AC06-44FF4690C577 wds:Q58448092-B0A450EE-D3A9-4DA6-88A3-86ACE09B37AB wds:Q58448092-2BDF4820-DFC2-4B7C-B6D2-7420C9248828 wds:Q58448092-0BA07C84-87ED-47D6-A0EF-1F3730F5BCAF

wdt:P2093

Michael Nauck Wolfgang E Schmidt Jason H Brett Nicoline Videbæk Alan Garber

rdfs:label

Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Tria Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes

skos:prefLabel

Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Tria

schema:name

Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Tria Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes

p:P50

wds:Q58448092-F884A23B-239D-4866-ADDF-0DE0633CC7EC wds:Q58448092-FDEEE4E6-EE84-4D61-9435-26631CA2232E wds:Q58448092-894789FB-2D23-4D92-B7AF-48992BA1DD9A

wdt:P50

wd:Q6224073 wd:Q28373106 wd:Q60996888

p:P1476

wds:Q58448092-162D96AE-13CF-48BF-A08A-7AF9180B7B09

wdt:P1476

Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials

p:P304

wds:Q58448092-34EF4CA8-AF06-4BFE-BA32-0758AF4C86C9

wdt:P304

1695-1702

p:P31

wds:Q58448092-C324E06D-B3D9-4D78-8F58-E577DD2978FD

wdt:P31

wd:Q13442814

p:P921

wds:Q58448092-54377DBA-355C-4FFB-A411-E6D2B3899305 wds:Q58448092-EF6C60CF-3AF1-48A2-819F-4DF41ECF6695

wdt:P921

wd:Q79460 wd:Q2526479

p:P698

wds:Q58448092-6A953551-688C-4E59-906E-D8929460A091

wdtn:P698

n12:21450987

wdt:P698

21450987

p:P1433

wds:Q58448092-D5634BDF-EF36-4021-B520-05156522AA76

wdt:P1433

wd:Q3186902

p:P433

wds:Q58448092-14BBFE87-C15E-4685-BA7A-05A461A54B80

p:P478

wds:Q58448092-9B803FA5-9860-413A-AA06-277858FD44E2

wdt:P433

6

wdt:P478

96

p:P356

wds:Q58448092-468B8AC7-D00F-4ECB-8BF2-1A32898DA8C3

wdtn:P356

n11:JC.2010-2822

wdt:P356

10.1210/JC.2010-2822